← Back to Clinical Trials
Recruiting NCT06275009

NCT06275009 Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06275009
Status Recruiting
Phase
Sponsor China National Center for Cardiovascular Diseases
Condition Lifestyle
Study Type OBSERVATIONAL
Enrollment 18,512 participants
Start Date 2023-12-11
Primary Completion 2026-12-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 59 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 18,512 participants in total. It began in 2023-12-11 with a primary completion date of 2026-12-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The incidence and prevalence of metabolic risk factors such as obesity, hypertension, diabetes, and dyslipidemia, as well as cardiovascular diseases (CVD), are continuously rising among the occupational population in China, primarily comprising the middle-aged and young adults. Unhealthy lifestyles and declining physical fitness are independent risk factors affecting cardiovascular health. Additionally, the level of physical fitness is influenced by postnatal lifestyles. Lifestyle factors related to cardiovascular health in the occupational population encompass various aspects, including smoking, physical activity, diet, sleep, psychological stress, etc. These factors may interact or have a synergistic effect, necessitating a comprehensive assessment. This project proposes a prospective cohort study design to establish a monitoring cohort for lifestyle and physical fitness among the occupational population. The study will track and follow individuals with or without any CVD metabolic risk factors, collecting information on general status, lifestyle, physical fitness, and health examination data. Exposure factors such as lifestyle and physical fitness will be measured annually, and the occurrence of CVD-related health outcomes will be observed. The aim is to develop a comprehensive evaluation index for cardiovascular health lifestyle, analyze the direct and indirect impacts of lifestyle and physical fitness on the occurrence and development of CVD, and explore potential mediating and moderating effects of physical fitness in the association between lifestyle and cardiovascular health.

Eligibility Criteria

Inclusion Criteria: * adults between 18-59 years of age * occupational staff * willing to accept long-term follow-up Exclusion Criteria: * participants with previous CVD history such as myocardial infarction, stroke and severe aortic stenosis; * with cancer; * with congenital genetic diseases, or cannot cooperate with the investigation and follow-up due to acquired diseases, such as congenital heart disease, paralysis, deafness, dementia, mental abnormality, developmental retardation, etc.; * with exercise contraindications; * duration of pregnancy; * refuse to sign the informed consent.

Contact & Investigator

Central Contact

Hongyi Du, MD PhD

✉ duhy@bjmu.edu.cn

📞 86-10-88396087

Frequently Asked Questions

Who can join the NCT06275009 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Lifestyle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06275009 currently recruiting?

Yes, NCT06275009 is actively recruiting participants. Contact the research team at duhy@bjmu.edu.cn for enrollment information.

Where is the NCT06275009 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06275009 clinical trial?

NCT06275009 is sponsored by China National Center for Cardiovascular Diseases. The trial plans to enroll 18,512 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology